Research ArticleCardiovascular Biology
A peptide of the RGS domain of GRK2 binds and inhibits Gαq to suppress pathological cardiac hypertrophy and dysfunction
- Sarah M. Schumacher1,2,
- Erhe Gao1,
- Maya Cohen3,
- Melissa Lieu1,2,
- J. Kurt Chuprun1,2, and
- Walter J. Koch1,2,*
- 1Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
- 2Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
- 3Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
- ↵*Corresponding author. E-mail: walter.koch{at}temple.edu
See allHide authors and affiliations
Science Signaling 22 Mar 2016:
Vol. 9, Issue 420, pp. ra30
DOI: 10.1126/scisignal.aae0549
Vol. 9, Issue 420, pp. ra30
DOI: 10.1126/scisignal.aae0549
Sarah M. Schumacher
Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
Erhe Gao
Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
Maya Cohen
Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
Melissa Lieu
Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
J. Kurt Chuprun
Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
Walter J. Koch
Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA.
